Literature DB >> 21547892

Prediction of pulmonary hypertension related to systemic sclerosis by an index based on simple clinical observations.

Christophe Meune1, Jérôme Avouac, Paolo Airò, Lorenzo Beretta, Philippe Dieudé, Karim Wahbi, Paola Caramaschi, Kiet Tiev, Susanna Cappelli, Elisabeth Diot, Alessandra Vacca, Jean-Luc Cracowski, Jean Sibilia, André Kahan, Marco Matucci-Cerinic, Yannick Allanore.   

Abstract

OBJECTIVE: To develop a score to estimate the risk of developing pulmonary hypertension (PH) in patients with systemic sclerosis (SSc).
METHODS: We first examined the prevalence and characteristics of precapillary PH confirmed by right-heart catheterization in a cross-sectional (derivation) sample of 1,165 SSc patients, and we developed a risk prediction score (RPS) based on simple clinical observations associated with PH. We next prospectively tested the 3-year predictive power of the "Cochin RPS" in a separate (validation) sample of 443 patients presenting with PH-free SSc at baseline.
RESULTS: In the derivation sample, age, forced vital capacity, and diffusing capacity for carbon monoxide/alveolar volume were independently associated with the presence of PH and were used to create the Cochin RPS. PH developed during followup in 20 patients in the validation sample. The area under the receiver operating characteristic curve of the Cochin RPS was 0.87 (95% confidence interval 0.79-0.95). With a cutoff value of 2.73, patients at risk of PH during followup could be identified with 89.5% sensitivity and 74.1% specificity. PH occurred in 0.6% of patients in the lowest 2 quintiles of the Cochin RPS, in 1.7% of patients in the third and fourth quintiles, and in 17.1% of patients in the highest quintile (P<0.0001 by log rank test). Patients in the highest quintile incurred a >35-fold higher risk of developing PH compared with patients in the 2 lowest quintiles (P=0.001).
CONCLUSION: Using routine clinical observations, we developed a simple score that accurately predicted the risk of PH in SSc.
Copyright © 2011 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2011        PMID: 21547892     DOI: 10.1002/art.30432

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  17 in total

1.  Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension.

Authors:  Dinesh Khanna; Heather Gladue; Richard Channick; Lorinda Chung; Oliver Distler; Daniel E Furst; Eric Hachulla; Marc Humbert; David Langleben; Stephen C Mathai; Rajeev Saggar; Scott Visovatti; Nezam Altorok; Whitney Townsend; John FitzGerald; Vallerie V McLaughlin
Journal:  Arthritis Rheum       Date:  2013-12

Review 2.  [Therapeutic management in early disease stages of systemic sclerosis : early diagnosis - early symptoms - early problems].

Authors:  M Frerix; F M P Meier; W Hermann; U Müller-Ladner
Journal:  Z Rheumatol       Date:  2013-12       Impact factor: 1.372

Review 3.  Screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension: a systematic review.

Authors:  Heather Gladue; Nezam Altorok; Whitney Townsend; Vallerie McLaughlin; Dinesh Khanna
Journal:  Semin Arthritis Rheum       Date:  2013-09-05       Impact factor: 5.532

4.  Systemic Sclerosis and Pulmonary Disease.

Authors:  Khoa Ngo
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Combination of echocardiographic and pulmonary function test measures improves sensitivity for diagnosis of systemic sclerosis-associated pulmonary arterial hypertension: analysis of 2 cohorts.

Authors:  Heather Gladue; Virginia Steen; Yannick Allanore; Rajeev Saggar; Rajan Saggar; Paul Maranian; Veronica J Berrocal; Jerome Avouac; Christophe Meune; Mona Trivedi; Dinesh Khanna
Journal:  J Rheumatol       Date:  2013-08-15       Impact factor: 4.666

6.  Vascular complications in systemic sclerosis: a prospective cohort study.

Authors:  Christopher A Mecoli; Ami A Shah; Francesco Boin; Fredrick M Wigley; Laura K Hummers
Journal:  Clin Rheumatol       Date:  2018-05-26       Impact factor: 2.980

7.  Six-Minute Walk Test as a Predictor of Diagnosis, Disease Severity, and Clinical Outcomes in Scleroderma-Associated Pulmonary Hypertension: The DIBOSA Study.

Authors:  Abhishek Gadre; Christian Ghattas; Xiaozhen Han; Xiaofeng Wang; Omar Minai; Kristin B Highland
Journal:  Lung       Date:  2017-06-23       Impact factor: 2.584

8.  Changes in estimated right ventricular systolic pressure predict mortality and pulmonary hypertension in a cohort of scleroderma patients.

Authors:  Ami A Shah; Shang-En Chung; Fredrick M Wigley; Robert A Wise; Laura K Hummers
Journal:  Ann Rheum Dis       Date:  2012-08-11       Impact factor: 19.103

9.  Comparison of different measures of diffusing capacity for carbon monoxide (DLCO) in systemic sclerosis.

Authors:  Marie Hudson; Deborah Assayag; Melissa Caron; Benjamin D Fox; Andrew Hirsch; Russell Steele; Rebecca Gaudreau-Taillefer; Solène Tatibouet; Lawrence Rudski; Murray Baron
Journal:  Clin Rheumatol       Date:  2013-06-04       Impact factor: 2.980

Review 10.  Systemic sclerosis-associated pulmonary arterial hypertension.

Authors:  Neal F Chaisson; Paul M Hassoun
Journal:  Chest       Date:  2013-10       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.